2'-(4-FLUOROPHENYL)-11.BETA.,17.ALPHA.,21-TRIHYDROXY-16.ALPHA.-METHYL-20-OXO-PREGN-4-ENO(3,2-C)PYRAZOLE
UNII 2QA63ME84N
Substance Identification & Data
This profile provides standardized clinical and technical data for 2'-(4-fluorophenyl)-11.beta.,17.alpha.,21-trihydroxy-16.alpha.-methyl-20-oxo-pregn-4-eno(3,2-c)pyrazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2QA63ME84N.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 23277-64-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H35FN2O4 YMIFNYJAQYOIPZ-QCGIRGIYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2'-(4-fluorophenyl)-11.beta.,17.alpha.,21-trihydroxy-16.alpha.-methyl-20-oxo-pregn-4-eno(3,2-c)pyrazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.